Chopin’s Etude in CMV Major

Register Now

28 June, 2024 10:00 a.m. to 11:00 a.m. EDT

  • Advanced Heart Failure & Transplantation
  • Advanced Lung Failure & Transplantation
  • Committees & Communities
  • Infectious Diseases
  • Professional Communities
  • Webinar
Thumbnail for Infectious Diseases Professional Community Webinars

CMV remains a significant challenge in solid organ transplant recipients, with impact on allograft function and toxicities related to treatment. The past several years has been notable for new approaches for prophylaxis and treatment, and greater understanding of the antigen-specific immune response. New antiviral medications (including letermovir and maribavir) and immune monitoring developments have the potential to transform the field. This session will allow for discussion of new approaches to prevention, prophylaxis, treatment, and patient risk stratification.


Maheen Abidi, MD, FIDSA, FAST
Bradley Gardiner, MBBS, FRACP, PhD


New CMV drugs: Letermovir and Maribavir
Presented by Jennifer Chow, MD

CMV and Telomere Disease
Presented by Marie Budev DO, MPH FCCP

CMV-Cell Mediated Immunity
Presented by Oriol Manuel, MD